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1. Introduction 
Development of straightforward and selective synthetic 
methods for enantioselective C-C bond formation is a 
fundamental goal in the area of synthetic organic chemistry.1  
Asymmetric allylic alkylation of prochiral or racemic substrates 
is one of the most effective synthetic methods to construct 
stereochemically defined chiral centers.2  The well-established 
nucleophilic substitution of activated allylic fragments is among 
the most useful and direct stereoselective methods for the 
functionalization of a variety of carbon-nucleophiles.3  Over the 
last decade, our laboratory has reported Pd-catalyzed 
decarboxylative allylic alkylation reactions (Scheme 1).  Since 
our initial efforts in this area, leading to the formation of α-
quaternary ketones 2 from racemic β-ketoesters 1 in good yields 
and enantioselectivities using (S)-4-(tert-butyl)-2-(2-
(diphenylphosphino)phenyl)-4,5-dihydrooxazole [(S)-t- 
BuPHOX]4 as a chiral ligand,5 we have expanded the scope6 and 
demonstrated the use of these methods in a number of 
applications.7  We recently developed the asymmetric allylic 
alkylation, giving α-quaternary lactams 4 from racemic β-
amidoesters 3 using (S)-2-(2-(bis(4-
(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-
4-(tert-butyl)-4,5-dihydrooxazole [(S)-(CF3)3-t-BuPHOX]8 as a 
chiral ligand.9  In the context of preparing trisubstituted tertiary 
stereocenters (i.e., Scheme 2, 3a), this methodology encountered 
problems; (1) allylic alkylation of β-amidoester 3a gave a 
mixture of mono-, di-allylated and unallylated lactams, and (2) 
the ee value of 4a produced was low (Scheme 2a).  This low 
mono-allylation selectivity is attributed to the fact that a 
deprotonated β-carboxyamides can serve as a nucleophile to form 
α-allyl-β-carboxyamides, eventually leading to di-allylated 
products.  Rare exceptions are found in recent work wherein we 
achieved the synthesis of α-secondary ketopiperazines,9b and 
some other groups developed asymmetric alkylation constructing 
trisubstituted chiral centers at  the α-position of amides.10   
 
 
Scheme 1. Allylic alkylation of ketones and lactams using 
Pd(0) complex and chiral P–N ligand system 
 
Since enol carbonates cannot undergo the unwanted 
background deprotonation and allylic alkylation reaction, catalyst 
controlled decarboxylative allylic alkylation of enol carbonates 
should generally proceed with high mono-allylic alkylation 
selectivity.  As expected, alkylation using enol carbonate 7a with 
Pd2(dba)3 and (S)-(CF3)-t-BuPHOX at 40 °C proceeded smoothly 
to give 4a in 90% yield with 99% ee (Scheme 2b).  This high 
enantioselectivity and yield is probably due to easy kinetic access 
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to an enolate allyl Pd complex, which was proposed by a DFT 
study in our previous report.11  Herein, we report the palladium-
catalyzed decarboxylative allylic alkylation of enol carbonates 
derived from lactams and ketones constructing trisubstituted 
chiral centers at the α-position of various carbonyl groups. 
 
 
Scheme 2. Comparison of β-amidoester (3a) and enol 
carbonate (7a). 
2. Results and Discussion 
The synthesis of enol carbonates 7a-f was difficult due to 
challenges associated with the formation of C-acylated 
compounds along with the desired O-acylated structures.  In 
order to selectively O-acylate the corresponding enolate, we 
screened bases, solvents and additives using methods previously 
employed for synthesizing enol carbonates.10b  Fortunately, 7a 
could be prepared from N-benzoylpiperidin-2-one by using 
potassium hexamethyldisilazide (KHMDS) with 18-crown-6 as 
an additive in THF (eq 1).  O-acylation of 4-benzoylmorpholin-3-
one (6b) proceeded without any additive, presumably due to a 
stabilization effect of the endocyclic oxygen atom to favor the 
enolate form (eq 2).  For thiomorpholine (6c), ε-caprolactam 
(6d), and azocan-2-one (6e), we used NaHMDS as a base and 
tetramethylethylenediamine (TMEDA) as an activator (eq 3).  
The 2-chloroallyl group was introduced by using 
allyloxycarbonyl imidazole as an acylating reagent and BF3•OEt2 
as an activator (eq 4). 
 
 
With the enol carbonate substrates in hand, we performed 
allylic alkylation reactions of lactam-derived enol carbonates 7b-
7f with Pd2(dba)3 (2.5 mol%) and (S)-(CF3)3-t-BuPHOX (6.25 
mol%) in toluene at 23 °C for 24 h (Scheme 3).  Reaction of 
carbonate 7b afforded morpholinone 4b in 73% yield and 94% 
ee.  Replacement of oxygen with sulfur gave thiomorpholinone 
4c in 82% yield but only 65% ee along with the formation of 
unallylated product 6b in 10% yield.  Caprolactam 7d was also 
reactive with this catalytic system by using tris(4,4’-
methoxydibenzylideneacetone)dipalladium(0) [Pd2(pmdba)3]12 as 
the palladium(0) source, furnishing lactam 4d in 83% yield and 
85% ee.  Chloride substitution at the 2-position of the allyl group 
in 7d increased the enantioselectivity, furnishing caprolactam 4f 
in 91% ee.  Ring size of the lactam significantly affected 
enantioselectivity, as the reaction of the 8-membered ring 
substrate 7e proceeded to give the amide 4e in 84% yield and 
59% ee.  
 
Scheme 3. Substrate scope of enol carbonates.  Reaction 
conditions: A mixture of 7 (0.20 mmol), Pd2(dba)3 (0.005 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 3 
mmol), and (S)-(CF3)3-t-BuPHOX (0.0125 mmol) in toluene 
(0.033 M) was stirred at 23 °C for 24 h.  Yield was isolated 
yield and enantiomeric excess was determined by chiral SFC 
analysis.  aPerformed at 50 °C.  bPerformed at 40 °C.  
c[Pd2(pmdba)3] was used as a catalyst. 
 
Next, we explored the scope of the allylation of ketones, 
forming α-tertiary alkyl(cyclo)alkanone derivatives.  We were 
pleased to discover that use of enol carbonate 8a, derived from 
the corresponding tetralone, resulted in a smooth reaction and 
delivered allylated tetralone 9a in high yield and 
enantioselectivity (eq 5).  It is noteworthy that the more 
challenging acyclic substrate 8b was reactive with this catalytic 
system as well, affording the corresponding ketone 9b in 99% 
yield and 81% ee (eq 6).13 
 
3. Conclusions 
Asymmetric allylic alkylation of enol carbonates is an 
effective method to construct trisubstituted chiral centers, which 
have been difficult to introduce using previously developed 
systems in our laboratory.  Herein, we report that a palladium/P–
N catalyst system displays activity for enol carbonates derived 
from lactams.  In addition, this system could be applied to the 
allylation of ketones in both cyclic and acyclic systems.  
4. Experimental section 
Materials and Methods:  Unless otherwise stated, reactions 
were performed in flame-dried glassware under an argon or 
nitrogen atmosphere using dry, deoxygenated solvents. Solvents 
were dried by passage through an activated alumina column 
under argon.14 Reaction progress was monitored by thin-layer 
chromatography (TLC) which was performed using E. Merck 
silica gel 60 F254 precoated glass plated (0.25 mm) and 
visualized by UV fluorescence quenching, or KMnO4 staining.  
Silicycle SiliaFlash® P60 Academic Silica gel (particle size 40-
63 nm) was used for flash chromatography. 1H and 13C NMR 
spectra were recorded on a Varian Inova 500 (500 MHz and 126 
MHz, respectively) and are reported in terms of chemical shift 
relative to CHCl3 (δ 7.26 and d 77.16, respectively).  Data for 1H 
NMR are reported as follows: chemical shift (δ ppm) 
(multiplicity, coupling constant (Hz), integration).  Multiplicities 
are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septet, m = multiplet, and br s = broad 
singlet.  IR spectra were obtained by use of a Perkin Elmer 
Spectrum BXII spectrometer using thin films deposited on NaCl 
plates and reported frequency of absorption (cm–1).  Optical 
rotations were measured with a Jasco P-2000 polarimeter 
operating on the sodium D-line (589 nm), using a 100 mm path-
length cell and are reported as: [α]DT (concentration in g/100mL, 
solvent).  Analytical SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing 
Chiralpak (AD-H, AS-H or IC) or Chiracel (OD-H, OJ-H or OB-
H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd.  High resolution mass spectra were obtained from 
the Caltech Mass Spectral Facility using a JEOL JMS-600H High 
Resolution Mass Spectrometer in fast atom bombardment 
(FAB+), or a Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI+), atmospheric 
pressure chemical ionization (APCI+), or mixed ionization mode 
(ESI/APCI). 
Reagents were purchased from Sigma-Aldrich, Acros Organics, 
Strem or Alfa Aesar and used as received unless otherwise stated.  
Et3N and tetramethylethylenediamine (TMEDA) were distilled 
from calcium hydride prior to use.  (S)-2-(2-(bis(4-
(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-
4-(tert-butyl)-4,5-dihydrooxazole [(S)-(CF3)3-t-BuPHOX]15 and 
tris(4,4’-methoxydibenzylideneacetone)dipalladium(0) 
[Pd2(pmdba)3]16 were prepared by known methods. 
4.1.  General Procedure for Asymmetric Allylic Alkylation 
Reactions  
In a nitrogen-filled glove box, [Pd2(dba)3] (4.6 mg, 0.005 
mmol, 0.025 equiv.) and (S)-(CF3)3-t-BuPHOX (7.4 mg, 0.0125 
mmol, 0.0625 equiv.) were added to a 20 mL scintillation vial 
equipped with a magnetic stirring bar.  The vial was then charged 
with toluene (4.0 mL) and stirred at 25 ºC for 30 min.  To the 
preformed catalyst solution was added a solution of enol 
carbonate (0.2 mmol, 1 equiv.) in toluene (2.1 mL).  The vial was 
sealed and stirred at 23 °C for 24 h. The reaction mixture was 
concentrated in vacuo. Flash column chromatography (SiO2) 
afforded α-allylated carbonyl compounds.  
 
4.1.1. 3-Allylpiperidin-2-one (4a). Reaction performed in toluene 
at 40 ºC.  Compound 4a was isolated by flash chromatography 
(SiO2, 7 to 10% EtOAc in hexanes) as a white solid. 90% yield. 
Rf = 0.31 (17% EtOAc in hexanes). M.p. 66.5-67.2 ºC; 99% ee, 
[α]D25 -77.1 (c 1.00, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.56-
7.50 (m, 2H), 7.47 (m, 1H), 7.42–7.35 (m, 2H), 5.77 (m, 1H), 
5.13–5.05 (m, 2H), 3.89–3.74 (m, 2H), 2.67–2.54 (m, 2H), 2.28 
(m, 1H), 2.14–2.02 (m, 2H), 1.96 (m, 1H), 1.68 (m, 1H). 13C 
NMR (126 MHz, CDCl3) δ 175.8, 174.8, 136.5, 135.6, 131.5, 
128.3, 127.9, 117.5, 46.2, 43.8, 35.3, 26.8, 22.1. IR (Neat Film, 
NaCl) 3073, 2947, 2870, 1699, 1679, 1641, 1478, 1367, 1288, 
1167, 1153, 1076, 1056, 1025, 1001 cm-1. HRMS (ESI+) m/z 
calc’d for C15H18NO2 [M+H]+: 244.1332, found 244.1372. SFC 
conditions: 5% MeOH, 2.5 mL/min, Chiralpak AD-H column, λ 
= 254 nm, tR (min): major = 9.10, minor = 6.18. 
 
4.1.2. 2-Allylmorpholin-3-one (4b). Reaction performed in 
toluene at 50 ºC.  Compound 4b was isolated by flash 
chromatography (SiO2, 7 to 10% EtOAc in hexanes) as a white 
solid. 73% yield. Rf = 0.52 (33% EtOAc in hexanes). 94% ee, 
[α]D25 -127.5 (c 0.80, CHCl3). 1H NMR (500 MHz, CDCl3) δ 
7.57–7.48 (m, 3H), 7.42–7.38 (m, 2H), 5.91 (m, 1H), 5.23–5.16 
(m, 2H), 4.23 (m, 2H), 4.04 (m, 1H), 3.93–3.82 (m, 2H), 2.73 (m, 
1H), 2.62 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 173.2, 171.3, 
135.7, 133.4, 132.0, 128.3, 128.2, 118.5, 78.5, 63.4, 45.3, 36.3. 
IR (Neat Film, NaCl) 3358, 3076, 2977, 2898, 2867, 1686, 1642, 
1601, 1583, 1463, 1449, 1432, 1398, 1374, 1301, 1282, 1228, 
1178, 1165, 1138, 1124, 1104 cm-1. HRMS (ESI+) m/z calc’d for 
C14H16NO3 [M+H]+: 246.1125, found 246.1124. SFC conditions: 
5% MeOH, 3.0 mL/min, Chiralpak OD-H column, λ = 254 nm, tR 
(min): major = 6.74, minor = 5.99. 
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4.1.3. 2-Allyl-4-benzoylthiomorpholin-3-one (4c). Reaction 
performed in toluene at 40 ºC. Compound 4c was isolated by 
flash chromatography (SiO2, 15% EtOAc in hexanes) as a white 
solid. 82% yield. Rf = 0.51 (33% EtOAc in hexanes). 65% ee, 
[α]D25 -31.1 (c 0.36, CHCl3). 1H NMR (500 MHz, CDCl3) δ 
7.61–7.57 (m, 2H), 7.51 (m, 1H), 7.45–7.38 (m, 2H), 5.85 (m, 
1H), 5.20–5.10 (m, 2H), 4.78 (ddd, J = 14.2, 4.8, 3.4 Hz, 1H), 
3.79 (dd, J = 7.7, 5.7 Hz, 1H), 3.73 (ddd, J = 14.2, 11.7, 4.2 Hz, 
1H), 3.16 (m, 1H), 3.10 (td, J = 11.7, 4.8 Hz, 1H), 2.76 (m, 1H), 
2.35 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 173.2, 171.6, 135.6, 
134.1, 132.0, 128.2, 128.1, 118.1, 43.6, 42.2, 33.3, 26.9. IR (Neat 
Film, NaCl) 3362, 3065, 2933, 1687, 1600, 1580, 1534, 1450, 
1378, 1326, 1281, 1177, 1132, 1071, 1026 cm-1. HRMS (FAB+) 
m/z calc’d for C14H16NO2S [M+H]+: 262.0902, found 262.0895. 
SFC conditions: 5% MeOH, 3.0 mL/min, Chiralcel OD-H 
column, λ = 254 nm, tR (min): major = 9.26, minor = 8.79. 
 
4.1.4. 3-Allyl-1-benzoylazepan-2-one (4d). Reaction performed in 
toluene at 40 °C.  Compound 4d was isolated by flash 
chromatography (SiO2, 10% EtOAc in hexanes) as a yellow oil. 
83% yield. Rf = 0.44 (17% EtOAc in hexanes). 85% ee, [α]D25 -
33.9 (c 1.90, CHCl3). 1H NMR (500 MHz, CDCl3) 7.55–7.49 (m, 
2H), 7.46 (m, 1H), 7.40–7.34 (m, 2H), 5.78 (m, 1H), 5.11–5.03 
(m, 2H), 4.56 (dd, J = 14.8, 5.8 Hz, 1H), 3.44 (ddd, J = 14.8, 
10.7, 0.9 Hz, 1H), 2.83 (m, 1H), 2.55 (m, 1H), 2.12–1.96 (m, 
3H), 1.90 (m, 1H), 1.74–1.44 (m, 3H). 13C NMR (126 MHz, 
CDCl3) δ 178.7, 174.5, 136.8, 136.2, 131.4, 128.1, 127.7, 117.1, 
45.9, 44.5, 36.4, 30.2, 28.8, 28.7. IR (Neat Film, NaCl) 3073, 
3030, 2931, 2857, 1681, 1641, 1600, 1583, 1513, 1490, 1450, 
1396, 1360, 1322, 1282, 1220, 1189, 1177, 1141, 1114, 1044, 
1018, 1001 cm-1. HRMS (ESI+) m/z calc’d for C16H20NO2 
[M+H]+: 258.1489, found 258.1494. SFC conditions: 5% MeOH, 
3.0 mL/min, Chiralcel AD-H column, λ = 254 nm, tR (min): 
major = 4.48, minor = 4.88. 
 
4.1.5. 3-Allyl-1-benzoylazocan-2-one (4e). Reaction performed in 
toluene at 23 °C. Compound 4e was isolated by flash 
chromatography (SiO2, 10% EtOAc in hexanes) as a yellow oil. 
84% yield. Rf = 0.50 (17% EtOAc in hexanes). 59% ee, [α]D25 -
8.6 (c 0.37, CHCl3). 1H NMR (300 MHz, CDCl3) δ 7.56–7.22 (m, 
5H), 5.80 (ddt, J = 17.2, 10.5, 6.9 Hz, 1H), 5.18–5.02 (m, 2H), 
4.19 (ddd, J = 15.1, 4.3, 3.0 Hz, 1H), 3.85 (ddd, J = 15.1, 12.6, 
2.8 Hz, 1H), 3.01 (m, 1H), 2.53 (m, 1H), 2.21–2.05 (m, 2H), 
1.92–1.70 (m, 4H), 1.70–1.35 (m, 3H). 13C NMR (126 MHz, 
CDCl3) δ 180.7, 174.9, 136.8, 136.1, 131.3, 128.1, 127.9, 117.4, 
45.1, 44.0, 38.0, 36.7, 31.2, 25.9, 24.5. IR (Neat Film, NaCl) 
3067, 2928, 2857, 1679, 1619, 1493, 1448, 1392, 1319, 1285, 
1246, 1176, 1125, 1091 cm-1. HRMS (ESI+) m/z calc’d for 
C17H22NO2 [M+H]+: 272.1645, found 272.1656. SFC conditions: 
5% MeOH, 3.0 mL/min, Chiralcel OJ-H column, λ = 254 nm, tR 
(min): major = 2.97, minor = 3.87. 
 
4.1.6. 1-Benzoyl-3-(2-chloroallyl)azepan-2-one (4f). Reaction 
performed in toluene at 23 ºC.  Compound 4f was isolated by 
flash chromatography (SiO2, 15% EtOAc in hexanes) as a yellow 
oil. 42% yield. Rf = 0.37 (17% EtOAc in hexanes). 91% ee, 
[α]D25 -78.1 (c 1.20, CHCl3). 1H NMR (500 MHz, CDCl3) δ 
7.56–7.50 (m, 2H), 7.46 (m, 1H), 7.41–7.29 (m, 2H), 5.26 (d, J = 
1.2 Hz, 1H), 5.19 (d, J = 1.2 Hz, 1H), 4.58 (dd, J = 15.1, 5.1 Hz, 
1H), 3.50 (dd, J = 15.1, 11.0 Hz, 1H), 3.23 (m, 1H), 2.85 (ddd, J 
= 14.6, 6.4, 1.0 Hz, 1H), 2.32 (ddd, J = 14.6, 7.7, 0.7 Hz, 1H), 
2.15–1.99 (m, 2H), 1.89 (m, 1H), 1.78–1.55 (m, 2H), 1.48 (m, 
1H). 13C NMR (126 MHz, CDCl3) δ 178.0, 174.5, 140.0, 136.7, 
131.6, 128.2, 127.9, 115.5, 44.7, 43.5, 41.6, 29.6, 28.9, 28.7. IR 
(Neat Film, NaCl) 2931, 2857, 1683, 1636, 1450, 1397, 1358, 
1321, 1274, 1220, 1188, 1148, 1126 cm-1. HRMS (ESI+) m/z 
calc’d for C16H19ClNO2 [M+H]+: 292.1099, found 292.1104. SFC 
conditions: 5% MeOH, 3.0 mL/min, Chiralcel OD-H column, λ = 
254 nm, tR (min): major = 5.89, minor = 4.97. 
 
4.1.7. 2-Allyl-3,4-dihydronaphthalen-1(2H)-one (9a). Reaction 
performed in toluene at 40 ºC. Compound 9a was isolated by 
flash chromatography (SiO2, 0 to 3% EtOAc in hexanes) as a 
pale colorless oil. 91% yield. Rf = 0.40 (9% EtOAc in hexanes). 
90% ee, [α]D25 +26.6 (c 0.61, CHCl3). 1H NMR (300 MHz, 
CDCl3) δ 8.04 (dd, J = 7.9, 1.5 Hz, 1H), 7.46 (td, J = 7.5, 1.5 Hz, 
1H), 7.36–7.16 (m, 2H), 5.95–5.75 (m, 1H), 5.18–5.01 (m, 2H), 
3.00 (dd, J = 7.8, 4.5 Hz, 2H), 2.76 (m, 1H), 2.55 (m, 1H), 2.36–
2.16 (m, 2H), 1.87 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 
199.5, 144.2, 136.4, 133.3, 132.8, 128.8, 127.7, 126.8, 116.9, 
47.4, 34.2, 28.8, 28.2. IR (Neat Film, NaCl) 3073, 2976, 2929, 
1686, 1682, 1640, 1600, 1455 1435, 1359, 1293, 1280, 1220, 
1156 cm-1. HRMS (ESI/APCI+) m/z calc’d for C13H15O [M+H]+: 
187.1117, found 187.1110. SFC conditions: 0.5% MeCN, 3.0 
mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 
8.11, minor = 7.74. 
 
4.1.8. 2-Methyl-1-phenylpent-4-en-1-one (9b). Reaction 
performed in toluene at 23 °C. Compound 9b was isolated by 
flash chromatography (SiO2, 0 to 3% EtOAc in hexanes) as a 
colorless oil. Quant. Rf = 0.43 (10% EtOAc in hexanes). 81% ee, 
[α]D25 -32.9 (c 0.50, CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 
8.02–7.97 (m, 2H), 7.60 (m, 1H), 7.55–7.47 (m, 2H), 5.83 (m, 
1H), 5.14–5.02 (m, 2H), 3.60 (m, 1H), 2.61 (m, 1H), 2.25 (m, 
1H), 1.26 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
203.6, 136.4, 135.8, 132.9, 128.7, 128.3, 116.8, 40.4, 37.6, 17.0. 
IR (Neat Film, NaCl) 3077, 2975, 2933, 2358, 1682, 1641, 1596, 
1579, 1447, 1374, 1360, 1239, 1209 cm-1. HRMS (ESI/APCI+) 
m/z calc’d for C12H15O [M+H]+: 175.1117, found 175.1113. SFC 
conditions: 0.5% MeCN, 3.0 mL/min, Chiralcel OD-H column, λ 
= 254 nm, tR (min): major = 3.97, minor = 4.42. 
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Materials and Methods 
   Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried by 
passage through an activated alumina column under argon.1  Reaction progress was 
monitored by thin-layer chromatography (TLC) which was performed using E. Merck 
silica gel 60 F254 precoated glass plated (0.25 mm) and visualized by UV fluorescence 
quenching, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel (particle 
size 40-63 nm) was used for flash chromatography. 1H and 13C NMR spectra were 
recorded on a Varian Inova 500 (500 MHz and 126 MHz, respectively) and are reported 
in terms of chemical shift relative to CHCl3 (δ 7.26 and d 77.16, respectively).  Data for 
1H NMR are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant 
(Hz), integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = 
triplet, q = quartet, p = pentet, sept = septet, m = multiplet, and br s = broad singlet.  IR 
spectra were obtained by use of a Perkin Elmer Spectrum BXII spectrometer using thin 
films deposited on NaCl plates and reported frequency of absorption (cm–1).  Optical 
rotations were measured with a Jasco P-2000 polarimeter operating on the sodium D-line 
(589 nm), using a 100 mm path-length cell and are reported as: [α]DT (concentration in 
g/100mL, solvent).  Analytical SFC was performed with a Mettler SFC supercritical CO2 
analytical chromatography system utilizing Chiralpak (AD-H, AS-H or IC) or Chiracel 
(OD-H, OJ-H or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd.  High resolution mass spectra were obtained from the Caltech Mass 
Spectral Facility using a JEOL JMS-600H High Resolution Mass Spectrometer in fast 
atom bombardment (FAB+), or a Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI+), atmospheric pressure chemical 
ionization (APCI+), or mixed ionization mode (ESI/APCI).   
   Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem or Alfa Aesar 
and used as received unless otherwise stated.  Et3N and tetramethylethylenediamine 
(TMEDA) were distilled from calcium hydride prior to use.  (S)-2-(2-(bis(4-
(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-4-(tert-butyl)-4,5-
dihydrooxazole [(S)-(CF3)3-t-BuPHOX]2 and tris(4,4’-
methoxydibenzylideneacetone)dipalladium(0) [Pd2(pmdba)3]3 were prepared by known 
methods. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Synthesis of Enol Carbonate Substrates 
   The following scheme shows a synthetic scheme of enol carbonates (Scheme S1).  
Lactams were prepared in two steps from cyclic ketones.  Subsequent benzoyl protection 
and acylation of the lactams led to the formation of enol carbonates.  Synthesis of 7-
membered substrates started from commercially available ε-caprolactam.  To introduce 
2-substituted allyl groups, the corresponding allyloxycarbonyl imidazoles were used 
instead of allyl chloroformate.  2-Chloroallyl group was successfully introduced using the 
typical procedure, while 2-methylallyl and 2-phenylallyl groups could not be introduced. 
  
Scheme S1. Typical synthetic scheme of enol carobonates 
 
 
General procedure for the preparation of enol carbonate. To a solution of amide (10 
mmol, 1.0 equiv) in THF (100 mL) was added a 2.5 M solution nBuLi in THF (11 mmol, 
1.1 equiv) at –78 ºC.  The resulting solution was stirred at –78 ºC for 30 min.  Then, 
benzoyl chloride (11 mmol, 1.1 equiv) was added at –78 ºC.  After completion of the 
addition, the reaction mixture was allowed to warm to room temperature.  All volatiles 
were removed in vacuo.  After the addition of EtOAc, the organic layer was washed with 
1 M HCl, saturated NaHCO3 aq and brine, dried over Na2SO4, filtered, and concentrated 
in vacuo.  The crude product was purified by flash column chromatography (SiO2, 
15→50% EtOAc in hexanes) to give the Bz-protected amide. To a stirred solution of 
NaHMDS (3 mmol, 1.5 equiv) in THF (30 mL) was added a solution of Bz-protected 
amide (2 mmol, 1.0 equiv) and TMEDA (2.2 mmol, 1.1 equiv) in THF dropwise via 
syringe at –78 ºC.  After stirring for 30 min, allyl chloroformate (2.2 mmol, 1.1 equiv) 
was added at –78 ºC.  The reaction was quenched by the addition of NH4Cl aq, and then 
the resulting mixture was extracted with ether. The combined organic layers were dried 
over Na2SO4, and concentrated in vacuo.  The crude product was purified by flash 
column chromatography (SiO2, 20% EtOAc in hexanes) to give the enol carbonate.  
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Allyl (1-benzoyl-1,4,5,6-tetrahydropyridin-2-yl) carbonate (7a). Compound 7a was 
obtained from piperidin-2-one according to the general procedure. 1H NMR (500 MHz, 
CDCl3) δ 7.61–7.55 (m, 2H), 7.48 (m, 1H), 7.45–7.39 (m, 2H), 5.84 (m, 1H), 5.35–5.24 
(m, 2H), 5.11 (t, J = 3.8 Hz, 1H), 4.52 (d, J = 5.8 Hz, 2H), 3.88–3.82 (m, 2H), 2.35 (td, J 
= 6.6, 3.8 Hz, 2H), 1.97–1.89 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 168.9, 152.0, 
140.9, 136.0, 130.9, 130.7, 128.2, 127.7, 119.3, 102.4, 69.1, 46.0, 23.1, 21.8.  IR (Neat 
Film, NaCl) 3520, 3290, 2917, 1765, 1644, 1451, 1367, 1263, 1224, 1039 cm-1.  HRMS 
(ESI/APCI) m/z calc’d for C16H18NO4 [M+H]+: 288.1230, found 288.1227.  
 
 
Allyl (4-benzoyl-3,4-dihydro-2H-1,4-oxazin-5-yl) carbonate (7b). To a solution of ethanol 
amine (197 mmol, 1.1 equiv) in iPrOH (100 mL) was portionwise added small pieces of 
sodium (197 mmol, 1.1 equiv). The mixture was heated at 50 °C for 5 h, and the resulting 
yellow solution was cooled in an ice-water bath. Ethyl chloroacetate (179 mmol, 1.0 
equiv) was dropwise added at 0 °C, and the resulting yellow suspension was heated at 
80 °C for 2 h. Insoluble materials were removed by paper filtration and washed with 
iPrOH. The combined filtrate and washings were concentrated in vacuo, and the resulting 
brown solids were recrystallized from iPrOH/EtOAc to afford 3-morpholinone in 52% 
yield.  To a solution of 3-morpholinone (9.9 mmol, 1.0 equiv) in THF (100 mL) was 
added a 2.5 M solution nBuLi in THF (10.9 mmol, 1.1 equiv) at –78 ºC.  The resulting 
solution was stirred at –78 ºC for 30 min.  Then, benzoyl chloride (10.9 mmol, 1.1 equiv) 
was added at –78 ºC.  After completion of the addition, the reaction mixture was allowed 
to warm to room temperature.  All volatiles were removed in vacuo. After the addition of 
EtOAc, the organic layer was washed with 1 M HCl, saturated NaHCO3 aq and brine, 
dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was purified 
by flash column chromatography (SiO2, 15→50% EtOAc in hexanes) to give the Bz-
protected amide in 71% yield.  To a stirred solution of LHMDS (3 mmol, 1.5 equiv) in 
THF (30 mL) was added a solution of Bz-protected amide (2 mmol, 1.0 equiv) in THF 
dropwise via syringe at –78 ºC.  After stirring for 30 min, allyl chloroformate (2.2 mmol, 
1.1 equiv) was added at –78 ºC.  The reaction was quenched by the addition of saturated 
NH4Cl aq, and then the resulting mixture was extracted with ether. The combined organic 
layers were dried over Na2SO4, and concentrated in vacuo.  The crude product was 
purified by flash column chromatography (SiO2, 20% EtOAc in hexanes) to give the enol 
carbonate in 61% yield.  1H NMR (500 MHz, CDCl3) δ 7.59–7.55 (m, 2H), 7.49–7.38 (m, 
3H), 6.31 (s, 1H), 5.80 (ddt, J = 16.5, 10.4, 5.8 Hz, 1H), 5.29–5.22 (m, 2H), 4.49 (d, J = 
5.8 Hz, 2H), 4.18–4.14 (m, 2H), 3.93–3.89 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 
167.2, 152.8, 135.3, 131.1, 131.0, 128.4, 128.1, 128.0, 126.6, 119.5, 69.5, 66.53, 42.6. IR 
(Neat Film, NaCl) 3062, 2944, 2884, 1769, 1698, 1653, 1602, 1580, 1493, 1448, 1393, 
1362, 1319, 1256, 1215, 1097, 1045 cm-1.  HRMS (ESI/APCI) m/z calc’d for C15H16NO5 
[M+H]+: 290.1023, found 290.1024.  
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Allyl (4-benzoyl-3,4-dihydro-2H-1,4-thiazin-5-yl) carbonate (7c). To a solution of 2-
aminoehtane-1-thiol (4.5 g, 40 mmol, 1.0 equiv) and K2CO3 (5.5 g, 40 mmol, 1.0 equiv.) 
in EtOH (80 mL) was added ethyl chloroacetate (40 mmol, 1 equiv). The resulting 
solution was stirred at room temperature for 2 h and at 75 ºC for 24 h.  After filtration, all 
volatiles were removed in vacuo. The crude product was purified by flash column 
chromatography (SiO2, EtOAc) to give thiomorpholin-3-one as white solid in 18% yield.  
To a cold solution (–78 ºC) of thiomorpholin-3-one (780 mg, 6.7 mmol, 1 equiv) in THF 
(20 mL) was added nBuLi (2.5 M in hexane, 0.85 mL, 7.3 mmol, 1.1 equiv) dropwise.  
After stirring for 30 min, benzoyl chloride (7.3 mmol, 1.1 equiv) was added at –78 ºC.  
The reaction mixture was warmed to room temperature and quenched by the addition of 
1M HCl, and then resulting mixture was extracted with EtOAc. The combined organic 
layers were dried over Na2SO4, and concentrated in vacuo.  The crude product was 
purified by flash column chromatography (SiO2, 20% EtOAc in hexanes) to give Bz-
protected lactam as yellow solid in 85% yield.  To a stirred solution of NaHMDS (2.05 g, 
11.2 mmol, 2.0 equiv) in THF (50 mL) was added a solution of Bz-protected lactam (1.25 
g, 5.6 mmol, 1.0 equiv) and TMEDA (840 µL, 5.6 mmol, 1.1 equiv) in THF (10 mL) 
dropwise via syringe at –78 ºC.  After stirring for 30 min, allyl chloroformate (590 mL, 
5.6 mmol, 1.0 equiv) was added at –78 ºC.  The reaction was quenched by the addition of 
saturated NH4Cl aq, and then the resulting mixture was extracted with ether.  The 
combined organic layers were dried over Na2SO4, and concentrated in vacuo.  The crude 
product was purified by flash column chromatography (SiO2, 40% EtOAc in hexanes) to 
give the enol carbonate as yellow oil in 39% yield. 1H NMR (500 MHz, CDCl3) δ 7.57–
7.52 (m, 2H), 7.47 (m, 1H), 7.42–7.37 (m, 2H), 5.76 (ddt, J = 17.5, 10.1, 5.8 Hz, 1H), 
5.70 (s, 1H), 5.28–5.20 (m, 2H), 4.44 (dt, J = 5.8, 1.4 Hz, 2H), 4.19–4.14 (m, 2H), 3.16–
3.10 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 168.1, 151.8, 135.4, 135.0, 131.0, 130.6, 
128.3, 127.4, 119.5, 100.4, 69.2, 42.6, 28.5. IR (Neat Film, NaCl) 3067, 2942, 2359, 
1764, 1664, 1638, 1601, 1579, 1491, 1448, 1364, 1320, 1276, 1244, 1226, 1190, 1162, 
1138, 1100, 1029 cm-1. HRMS (ESI/APCI) m/z calc’d for C15H16NO4S [M+H]+: 
306.0795, found 306.0786. 
 
 
Allyl (1-benzoyl-4,5,6,7-tetrahydro-1H-azepin-2-yl) carbonate (7d). Compound 7d was 
obtained from ε-caprolactam according to the general procedure. 1H NMR (500 MHz, 
CDCl3) δ 7.57–7.51 (m, 2H), 7.48 (m, 1H), 7.44–7.37 (m, 2H), 5.85 (ddt, J = 16.4, 10.9, 
5.7 Hz, 1H), 5.47 (t, J = 6.8 Hz, 1H), 5.35–5.25 (m, 2H), 4.53 (d, J = 5.7 Hz, 2H), 3.97 
(br s, 2H), 2.34 (td, J = 6.8, 4.3 Hz, 2H), 1.92 (br s, 2H), 1.75–1.68 (m, 2H). 13C NMR 
(126 MHz, CDCl3) δ 169.3, 152.6, 146.1, 136.0, 131.0, 130.5, 128.3, 127.0, 119.4, 112.2, 
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69.1, 46.5, 29.8, 24.9, 23.9. IR (Neat Film, NaCl) 2943, 2359, 1761, 1653, 1448, 1374, 
1325, 1243, 1172, 1134, 1094 cm-1. HRMS (ESI+) m/z calc’d for C17H20NO4 [M+H]+: 
302.1387, found 302.1372. 
 
 
(E)-Allyl (1-benzoyl-1,4,5,6,7,8-hexahydroazocin-2-yl) carbonate (7e).  In a 100 mL flask 
equipped with magnetic stirrer and containing 30 mL of EtOH, cycloheptanone (50 
mmol) and NH2OH•HCl (80 mmol) were dissolved.  To the above solution was added 
K2CO3 (40 mmol) in H2O (30 mL) dropwise.  The mixture was stirred at 50 ºC for 2 h.  
After removal of all volatiles, aqueous phase was extracted with CH2Cl2.  The combined 
organic layers were dried over Na2SO4, and concentrated in vacuo to give 
cycloheptanone oxime in 61% yield. To a hot solution (110 ºC) of H2SO4 (10 mL) in H2O 
(3 mL) was added cycloheptanone oxime (20 mmol) dropwise or several portions. After 
completion of the addition, the reaction mixture was cooled to 0 ºC and neutralized with 
NaOH. The aqueous phase was extracted with CH2Cl2. The combined organic layers 
were dried over Na2SO4, and concentrated in vacuo to give the corresponding amide in 
69% yield.  To a solution of amide (10 mmol, 1.0 equiv) in THF (100 mL) was added a 
2.5 M solution nBuLi in THF (11 mmol, 1.1 equiv) at –78 ºC.  The resulting solution was 
stirred at –78 ºC for 30 min.  Then, benzoyl chloride (11 mmol, 1.1 equiv) was added at –
78 ºC. After completion of the addition, the reaction mixture was allowed to warm to 
room temperature.  All volatiles were removed in vacuo.  After the addition of EtOAc, 
the organic layer was washed with 1 M HCl, saturated NaHCO3 aq and brine, dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by flash 
column chromatography (SiO2, 15→50% EtOAc in hexanes) to give the Bz-protected 
amide in 91% yield. To a stirred solution of NaHMDS (3 mmol, 1.5 equiv) in THF (30 
mL) was added a solution of Bz-protected azocan-2-one (2 mmol, 1.0 equiv) and 
TMEDA (2.2 mmol, 1.1 equiv) in THF dropwise via syringe at –78 ºC.  After stirring for 
30 min, allyl chloroformate (2.2 mmol, 1.1 equiv) was added at –78 ºC.  The reaction was 
quenched by the addition of saturated NH4Cl aq, and then the resulting mixture was 
extracted with ether.  The combined organic layers were dried over Na2SO4, and 
concentrated in vacuo.  The crude product was purified by flash column chromatography 
(SiO2, 20% EtOAc in hexanes) to give the enol carbonate in 36% yield.  1H NMR (500 
MHz, CDCl3) δ 7.62–7.57 (m, 2H), 7.45 (m, 1H), 7.39 (dd, J = 8.2, 6.6 Hz, 2H), 5.97 
(ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.50–5.30 (m, 3H), 4.67 (dt, J = 5.9, 1.4 Hz, 2H), 3.87 
(br s, 2H), 2.14–2.07 (m, 2H), 1.98–1.93 (m, 2H), 1.84–1.73 (m, 4H). 13C NMR (126 
MHz, CDCl3) δ 171.4, 153.4, 141.2, 135.8, 131.0, 130.3, 127.9, 127.1, 119.7, 118.7, 69.2, 
48.2, 26.8, 25.4. IR (Neat Film, NaCl) 3059, 2932, 2855, 1759, 1660, 1601, 1579, 1493, 
1447, 1360, 1333, 1235, 1218, 1190, 1156, 1116, 1085, 1026 cm-1. HRMS (ESI/APCI) 
m/z calc’d for C18H22NO4 [M+H]+: 316.1543, found 316.1544. 
 
BzN
O O
O
8
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
1-Benzoyl-4,5,6,7-tetrahydro-1H-azepin-2-yl (2-chloroallyl) carbonate (7f). Compound 
7f was obtained from ε-caprolactam with 2-chloroallyloxycarbonyl imidazole17 according 
to the general procedure. 1H NMR (500 MHz, CDCl3) δ 7.56–7.51 (m, 2H), 7.47 (m, 1H), 
7.43–7.38 (m, 2H), 5.50 (t, J = 6.7 Hz, 1H), 5.46–5.40 (m, 2H), 4.58 (s, 2H), 3.97 (br s, 
2H), 2.34 (td, J = 6.8, 4.4 Hz, 2H), 1.92 (br s, 2H), 1.77–1.63 (m, 2H). 13C NMR (126 
MHz, CDCl3) δ 169.2, 152.0, 145.9, 135.8, 134.48, 130.49, 128.2, 126.9, 115.7, 112.2, 
69.4, 46.4, 29.7, 24.8, 23.7. IR (Neat Film, NaCl) 2943, 2855, 1766, 1660, 1651, 1579, 
1492, 1446, 1372, 1352, 1326, 1260, 1242, 1195, 1173, 1134, 1095, 1011 cm-1. HRMS 
(ESI/APCI) m/z calc’d for C17H19ClNO4 [M+H]+: 336.0997, found 336.0995. 
 
 
Allyl (3,4-dihydronaphthalen-1-yl) carbonate (8a). 1H NMR (500 MHz, CDCl3) δ 7.27–
7.16 (m, 4H), 6.04 (ddt, J = 17.2, 10.5, 5.9 Hz, 1H), 5.86 (t, J = 4.7 Hz, 1H), 5.47 (ddd, J 
= 17.2, 1.5, 1.5 Hz, 1H), 5.37 (ddd, J = 10.5, 1.2, 1.2 Hz, 1H), 4.76 (dt, J = 5.9, 1.4 Hz, 
2H), 2.92 (t, J = 8.3 Hz, 2H), 2.50 (td, J = 8.3, 4.7 Hz, 2H). 13C NMR (126 MHz, CDCl3) 
δ 153.4, 146.1, 136.4, 131.2, 130.1, 128.1, 127.6, 126.5, 120.6, 119.4, 115.3, 69.1, 27.4, 
22.0. IR (Neat Film, NaCl) 3066, 3023, 2942, 2889, 2835, 1760, 1656, 1489, 1451, 1360, 
1338, 1223, 1185, 1135, 1013 cm-1. HRMS (FAB+) m/z calc’d for C14H13O3 [M-H]–: 
229.0865, found 229.0859. 
 
 
(Z)-Allyl (1-phenylprop-1-en-1-yl) carbonate (8b). 1H NMR (500 MHz, CDCl3) δ 7.53–
7.43 (m, 2H), 7.42–7.35 (m, 2H), 7.35–7.29 (m, 1H), 6.01 (ddt, J = 17.2, 10.4, 5.7 Hz, 
1H), 5.92 (q, J = 7.0 Hz, 1H), 5.44 (ddd, J = 17.2, 1.5, 1.5 Hz, 1H), 5.35 (ddd, J = 10.4, 
1.2, 1.2 Hz, 1H), 4.74 (dt, J = 5.7, 1.4 Hz, 2H), 1.84 (d, J = 7.0 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 152.8, 147.3, 134.7, 131.2, 128.5, 128.2, 124.3, 119.2, 113.0, 69.0, 11.3. 
IR (Neat Film, NaCl) 3060, 2919, 2356, 1759, 1674, 1495, 1446, 1381, 1318, 1225, 1185, 
1116, 1077 cm-1. HRMS (FAB+) m/z calc’d for C13H13O3 [M-H]–: 217.0865, found 
217.0866. 
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